Creating a Synergistic Foundation BPC-157 doesnt act alone
Data that remained non-normally distributed and/or heteroscedastic after log transformation were analyzed (not log-transformed, but still 1e13-transformed) with a KruskalWallis test, while normally distributed and homoscedastic data were analyzed with a one-way ANOVA, performed on the log-transformed data as necessary
Phase II at minimum, with a credible safety analysis
[5] Work on tissue-specific targeting and metabolic stability continues in research settings
However, a new frontier is emerging: BPC-157 in powder form , specifically for oral capsule delivery
Gut comfort and adherence Because researchers associate BPC-157 with gastric peptide research, some people link it to gut comfort and routine stability